Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy.
10.1007/s13238-012-2918-4
- Author:
Fei YI
1
;
Guang-Hui LIU
;
Juan Carlos IZPISUA BELMONTE
Author Information
1. Gene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
- Publication Type:Journal Article
- MeSH:
Cell Differentiation;
Cell- and Tissue-Based Therapy;
Drug Evaluation, Preclinical;
Hepatocytes;
cytology;
Humans;
Induced Pluripotent Stem Cells;
cytology;
transplantation;
Liver Diseases;
therapy;
Models, Biological
- From:
Protein & Cell
2012;3(4):246-250
- CountryChina
- Language:English
-
Abstract:
Recent advances in the study of human hepatocytes derived from induced pluripotent stem cells (iPSC) represent new promises for liver disease study and drug discovery. Human hepatocytes or hepatocyte-like cells differentiated from iPSC recapitulate many functional properties of primary human hepatocytes and have been demonstrated as a powerful and efficient tool to model human liver metabolic diseases and facilitate drug development process. In this review, we summarize the recent progress in this field and discuss the future perspective of the application of human iPSC derived hepatocytes.
